Connect
MJA
MJA

Stop taking warfarin? No way!

Amit K Verma and Ajai K Verma
Med J Aust 2009; 191 (10): 577-578.
Published online: 16 November 2009

To the Editor: Brukner’s personal perspective in a recent issue of the Journal highlights the inherent difficulty of managing patients taking warfarin.1 Although Brukner advocates life-long warfarin therapy for patients who have experienced a pulmonary embolism, we believe few clinicians would be willing to expose their patients to the increased risk of haemorrhage associated with long-term warfarin therapy, especially if a transient risk factor for venous thromboembolism (VTE) existed (such as frequent air travel, in Brukner’s case).

  • Amit K Verma
  • Ajai K Verma

  • Monash University, Melbourne, VIC.

Correspondence: amit_verma5@hotmail.com

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.